121 related articles for article (PubMed ID: 21484230)
1. Comparing the use of glycerol preserved and cryopreserved allogenic skin for the treatment of severe burns: differences in clinical outcomes and in vitro tissue viability.
Kua EH; Goh CQ; Ting Y; Chua A; Song C
Cell Tissue Bank; 2012 Jun; 13(2):269-79. PubMed ID: 21484230
[TBL] [Abstract][Full Text] [Related]
2. Viability of cryopreserved human skin allografts: effects of transport media and cryoprotectant.
Gaucher S; Elie C; Vérola O; Jarraya M
Cell Tissue Bank; 2012 Mar; 13(1):147-55. PubMed ID: 21305360
[TBL] [Abstract][Full Text] [Related]
3. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burn: a retrospective analysis.
Cleland H; Wasiak J; Dobson H; Paul M; Pratt G; Paul E; Herson M; Akbarzadeh S
Burns; 2014 Feb; 40(1):61-6. PubMed ID: 24018216
[TBL] [Abstract][Full Text] [Related]
4. Banking and use of glycerol preserved full-thickness skin allograft harvested from body contouring procedures.
Zidan SM; Eleowa SA
Burns; 2014 Jun; 40(4):641-7. PubMed ID: 24070848
[TBL] [Abstract][Full Text] [Related]
5. Comparison between cryopreserved and glycerol-preserved allografts in a partial-thickness porcine wound model.
Yoon C; Lim K; Lee S; Choi Y; Choi Y; Lee J
Cell Tissue Bank; 2016 Mar; 17(1):21-31. PubMed ID: 26150190
[TBL] [Abstract][Full Text] [Related]
6. Viability and efficacy of coverage of cryopreserved human skin allografts in mice.
Gaucher S; Nicco C; Jarraya M; Batteux F
Int J Low Extrem Wounds; 2010 Sep; 9(3):132-40. PubMed ID: 20705624
[TBL] [Abstract][Full Text] [Related]
7. Preservation methods of allografts and their (lack of) influence on clinical results in partial thickness burns.
Hermans MH
Burns; 2011 Aug; 37(5):873-81. PubMed ID: 21353745
[TBL] [Abstract][Full Text] [Related]
8. The application of glycerol-preserved skin allograft in the treatment of burn injuries: an analysis based on indications.
Khoo TL; Halim AS; Saad AZ; Dorai AA
Burns; 2010 Sep; 36(6):897-904. PubMed ID: 20299154
[TBL] [Abstract][Full Text] [Related]
9. A historical appraisal of the use of cryopreserved and glycerol-preserved allograft skin in the treatment of partial thickness burns.
Vloemans AF; Middelkoop E; Kreis RW
Burns; 2002 Oct; 28 Suppl 1():S16-20. PubMed ID: 12237059
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts.
Saegeman VS; Ectors NL; Lismont D; Verduyckt B; Verhaegen J
Burns; 2008 Mar; 34(2):205-11. PubMed ID: 18037568
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice of glycerol preserved allograft skin coverage.
Blome-Eberwein S; Jester A; Kuentscher M; Raff T; Germann G; Pelzer M
Burns; 2002 Oct; 28 Suppl 1():S10-12. PubMed ID: 12237057
[TBL] [Abstract][Full Text] [Related]
12. Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi.
Verbeken G; Verween G; De Vos D; Pascual B; De Corte P; Richters C; De Coninck A; Roseeuw D; Ectors N; Rose T; Jennes S; Pirnay JP
Cell Tissue Bank; 2012 Mar; 13(1):1-7. PubMed ID: 21360142
[TBL] [Abstract][Full Text] [Related]
13. Sterilisation of skin allograft with gamma irradiation.
Rooney P; Eagle M; Hogg P; Lomas R; Kearney J
Burns; 2008 Aug; 34(5):664-73. PubMed ID: 18226461
[TBL] [Abstract][Full Text] [Related]
14. Experience with banked skin in the Prague Burn Center.
Broz L; Vogtová D; Königová R
Acta Chir Plast; 1999; 41(2):54-8. PubMed ID: 10439519
[TBL] [Abstract][Full Text] [Related]
15. [Indication for and results of the application of glycerol-preserved homologous split-thickness skin following burns].
Bruck JC; Büttemeyer R; Grabosch A; Weyer A
Beitr Orthop Traumatol; 1990 Sep; 37(9):504-6. PubMed ID: 2248607
[TBL] [Abstract][Full Text] [Related]
16. Histological and mechanical evaluation of antifreeze peptide (Afp1m) cryopreserved skin grafts post transplantation in a rat model.
Ibrahim SM; Kareem OH; Saffanah KM; Adamu AA; Khan MS; Rahman MBA; Noordin MM; Loqman MY
Cryobiology; 2018 Jun; 82():27-36. PubMed ID: 29679551
[TBL] [Abstract][Full Text] [Related]
17. Treatment of second degree facial burns with allografts--preliminary results.
Horch RE; Jeschke MG; Spilker G; Herndon DN; Kopp J
Burns; 2005 Aug; 31(5):597-602. PubMed ID: 15993304
[TBL] [Abstract][Full Text] [Related]
18. Islet cryopreservation using intracellular preservation solutions.
Lakey JR; Rajotte RV; Fedorow CA; Taylor MJ
Cell Transplant; 2001; 10(7):583-9. PubMed ID: 11714192
[TBL] [Abstract][Full Text] [Related]
19. Lower extremity burns and Unna paste: can we decrease health care costs without compromising patient care?
Wells NJ; Boyle JC; Snelling CF; Carr NJ; Courtemanche DJ
Can J Surg; 1995 Dec; 38(6):533-6. PubMed ID: 7497369
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cryopreserved donor skin viability: the experience of the regional tissue bank of Siena.
Pianigiani E; Tognetti L; Ierardi F; Mariotti G; Rubegni P; Cevenini G; Perotti R; Fimiani M
Cell Tissue Bank; 2016 Jun; 17(2):241-53. PubMed ID: 26939692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
